These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7545886)

  • 1. No relationship of I1- and I2-imidazoline binding sites to inhibitory effects of imidazolines on ligand-gated ion channels. An investigation in the adrenal medulla and in neuroblastoma cells.
    Molderings GJ; Ruppert K; Bönisch H; Göthert M
    Ann N Y Acad Sci; 1995 Jul; 763():420-32. PubMed ID: 7545886
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of I1-imidazoline receptors using microphysiometry and molecular modelling.
    Musgrave IF; Hughes RA
    J Auton Nerv Syst; 1998 Oct; 72(2-3):137-46. PubMed ID: 9851562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazoline binding sites on PC12 cells and bovine chromaffin cells.
    Steffen G; Dendorfer A; Dominiak P
    Ann N Y Acad Sci; 1995 Jul; 763():157-62. PubMed ID: 7677325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of imidazoline sites I1 and I2 selective ligands.
    Anastassiadou M; Danoun S; Crane L; Baziard-Mouysset G; Payard M; Caignard DH; Rettori MC; Renard P
    Bioorg Med Chem; 2001 Mar; 9(3):585-92. PubMed ID: 11310592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
    King PR; Gundlach AL; Louis WJ
    Ann N Y Acad Sci; 1999 Jun; 881():161-70. PubMed ID: 10415911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazolines stimulate release of insulin from RIN-5AH cells independently from I1- and I2-imidazoline receptors.
    Olmos G; Kulkarni RN; Haque M; MacDermot J
    Ann N Y Acad Sci; 1995 Jul; 763():374-6. PubMed ID: 7677349
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel targets and techniques in imidazoline receptor research.
    Musgrave IF; Hughes RA
    Ann N Y Acad Sci; 1999 Jun; 881():301-12. PubMed ID: 10415931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazoline binding sites and signal transduction pathways.
    Musgrave IF; Krautwurst D; Schultz G
    Clin Exp Pharmacol Physiol; 1996; 23(10-11):990-4. PubMed ID: 8911748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [125I]2-(2-chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a high-affinity radioligand selective for I1 imidazoline receptors.
    Greney H; Urosevic D; Schann S; Dupuy L; Bruban V; Ehrhardt JD; Bousquet P; Dontenwill M
    Mol Pharmacol; 2002 Jul; 62(1):181-91. PubMed ID: 12065769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues.
    Gentili F; Bousquet P; Brasili L; Dontenwill M; Feldman J; Ghelfi F; Giannella M; Piergentili A; Quaglia W; Pigini M
    J Med Chem; 2003 May; 46(11):2169-76. PubMed ID: 12747788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of imidazolines and imidazoline receptors role at the vascular level.
    Serban DN; Nechifor M; Slătineanu SM
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):37-44. PubMed ID: 12089957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfected cells expressing the three subtypes of alpha 2-adrenergic receptors lack I1-imidazoline binding sites.
    Ordener C; Greney H; Devedjian J; Dontenwill M; Bousquet P; Parini A
    Ann N Y Acad Sci; 1999 Jun; 881():59-60. PubMed ID: 10415897
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gadolinium ion: a potent blocker of calcium channels and catecholamine release from cultured chromaffin cells.
    Bourne GW; Trifaró JM
    Neuroscience; 1982 Jul; 7(7):1615-22. PubMed ID: 6289176
    [No Abstract]   [Full Text] [Related]  

  • 16. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I1-imidazoline receptors: an update.
    Bousquet P; Dontenwill M; Greney H; Feldman J
    J Hypertens Suppl; 1998 Aug; 16(3):S1-5. PubMed ID: 9747903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells.
    Regunathan S; Meeley MP; Reis DJ
    Mol Pharmacol; 1991 Dec; 40(6):884-8. PubMed ID: 1758440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of imidazoline I2 binding sites in pig brain.
    Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
    Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.